Kalkine has a fully transformed New Avatar.

small-cap

Should You Exit This NASDAQ-Listed Energy Stock - CLNE

Apr 01, 2022 | Team Kalkine
Should You Exit This NASDAQ-Listed Energy Stock - CLNE

 

Clean Energy Fuels Corp.

Clean Energy Fuels Corp. (NASDAQ: CLNE) is a renewable energy company specializing in the procurement and distribution of renewable natural gas (RNG) and conventional natural gas (CNG), and liquefied natural gas (LNG) for the transportation markets in the United States and Canada.

Why Should Investors Make an Exit?

  • Weak Margin Profile: In FY21, CLNE’s reported Gross margin of 15.7% in the period under consideration which was lower than the 36.4% reported in the same period of the corresponding previous financial year. Its reported net margin was -36.8% vs. the industry median of 10.7%.
  • High Cash Conversion Days: Compared to the industry, the company has a long Cash Conversion Cycle (Days), meaning that it takes more days to convert its sales to cash. As of FY21, its Cash Cycle was 158 days, compared to an industry median of 4 days.
  • Technical weakness: CLNE price is trading below the horizontal trend line on the weekly chart and is meeting resistance from the same as well as the 50-period SMA. However, the price is trading above the 21-period SMA of the trend-following indicator, which could act as immediate support. Furthermore, the RSI (14-period) momentum oscillator is trading at 58.80, reverting from higher levels. The stock's main support level is set at USD 6.70, while the critical resistance level is set at USD 8.55.
  • Competition Risk: CLNE operates in a highly competitive vehicle fuel industry, and its product competes directly with gasoline and diesel in all its key markets. It also faces competition from suppliers of other alternative vehicle fuels and producers and fuelers of alternative vehicles, including hybrid, electric and hydrogen-powered vehicles. Should this competition intensify further, it could be detrimental to CLNE’s operating performance.

 

Valuation Methodology: EV/Sales Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

Stock Recommendation:

CLNE's share price has declined 20.50% in the past nine months and is currently leaning towards the lower band of the 52-week range of USD 4.70 to USD 14.77. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 6.98.

Considering the company's weak liquidity profile, longer cash cycle, current valuation and associated risks. We recommend a "Sell" rating on the stock at the closing price of USD 7.95, up 0.13% as of April 01, 2022.  

            

Three-Year Technical Price Chart (April 01, 2022). Source: REFINITIV, Analysis by Kalkine Group

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.